about
An ARHGEF10 deletion is highly associated with a juvenile-onset inherited polyneuropathy in Leonberger and Saint Bernard dogsAntiviral treatment for Bell's palsy (idiopathic facial paralysis)Antiviral treatment for Bell's palsy (idiopathic facial paralysis)Antiviral treatment for Bell's palsy (idiopathic facial paralysis)Antiviral treatment for Bell's palsy (idiopathic facial paralysis)Corticosteroids for Bell's palsy (idiopathic facial paralysis)Surgical versus non-surgical treatment for carpal tunnel syndromeSurgical versus non-surgical treatment for carpal tunnel syndromeCorticosteroids for Bell's palsy (idiopathic facial paralysis)Paraproteinemic neuropathy: a practical reviewSmall nerve fiber involvement in CMT1A.A deletion in the N-myc downstream regulated gene 1 (NDRG1) gene in Greyhounds with polyneuropathyClinical spectrum of cryoglobulinaemic neuropathySafety and efficacy of an add-on therapy with curcumin phytosome and piperine and/or lipoic acid in subjects with a diagnosis of peripheral neuropathy treated with dexibuprofenElectroacupuncture and splinting versus splinting alone to treat carpal tunnel syndrome: a randomized controlled trialLocal regulation of fat metabolism in peripheral nerves.Label-free photoacoustic microscopy of peripheral nerves.Early stages of building a rare disease registry, methods and 2010 data from the Belgian Neuromuscular Disease Registry (BNMDR).Quality improvement in neurology: Distal symmetric polyneuropathy quality measuresCamKII inhibitors reduce mitotic instability, connexon anomalies and progression of the in vivo behavioral phenotype in transgenic animals expressing a mutated Gjb1 gene.Facial exercise therapy for facial palsy: systematic review and meta-analysis.Determinants of reduced health-related quality of life in pediatric inherited neuropathies.An open-label, non-randomized comparison of venlafaxine and gabapentin as monotherapy or adjuvant therapy in the management of neuropathic pain in patients with peripheral neuropathyPeripheral neuropathy.The evaluation of distal symmetric polyneuropathy: a physician survey of clinical practice.Reliability of instrumented movement analysis as outcome measure in Charcot-Marie-Tooth disease: results from a multitask locomotor protocol.Clinical, neurophysiological, and skin biopsy findings in peripheral neuropathy associated with hepatitis C virus-related cryoglobulinemia.Hip flexion weakness is associated with impaired mobility in oculopharyngeal muscular dystrophy: a retrospective study with implications for trial design.H-index is important for postural control for people with impaired foot sole sensation.Effects of aging on laser evoked potentials.Is cardiovascular disease a risk factor in the development of axonal polyneuropathy?Should coeliac disease be considered in the work up of patients with chronic peripheral neuropathy?Impairments and comorbidities of polyneuropathy revealed by population-based analyses.Are human peripheral nerves sensitive to X-ray imaging?Axonal neuropathy in female carriers of the fragile X premutation with fragile x-associated tremor ataxia syndrome.Polymorphisms of GSTT1, GSTM1, and EPHX genotypes in patients with cryptogenic polyneuropathy: a case-control study.Involvement of Peripheral Nerves in the Transgenic PLP-α-Syn Model of Multiple System Atrophy: Extending the PhenotypeImpaired protein translation in Drosophila models for Charcot-Marie-Tooth neuropathy caused by mutant tRNA synthetasesEndometrial carcinoma presenting as vasculitic sensorimotor polyneuropathy.Incidence of common compressive neuropathies in primary care
P2860
Q21144864-F658FABF-20C6-434B-AE64-9A9A39F20DFCQ24186629-46A0B55E-066A-4242-AA87-D7241E041DE3Q24187405-81E46BF8-C427-4852-8D4F-260AC1FE585AQ24187837-2D9F35EA-36F4-4E11-8D26-00AA2AF41D6EQ24188059-0417A69F-F54F-42B5-93EC-8FD12D96E466Q24236770-D3C32A58-9F4B-4878-9378-52FBDB2B1DB6Q24241050-1AE81E3A-A8DE-4D12-B3B7-2B6D888D0CF6Q24248069-4D9A5AFE-E5A7-4CAF-ADA8-D8C1113E4EC1Q26471061-FCA3923E-8CE6-49B8-8759-B7A769274C52Q26773047-EBB01CFE-21CD-4067-AC97-08B77ACA06FEQ27312053-3A0A30E2-DA59-4A29-9593-498DB292C50AQ27324656-44A6B8FB-2910-47F7-AD38-BFEDD61C375AQ27477873-2491457E-EAF6-44B9-9E5F-0E28713A7632Q28385294-CCC5AC26-F398-43C0-835E-FF4AB385DF90Q28388275-6D80AB43-929E-4DE6-A761-1FF15CCE548CQ28510849-DCAEA6B3-75FC-4601-840B-43769F6DC7A4Q30421372-9C90E297-0E63-4F85-9AEC-FB3FE19A294CQ30832937-D0339A77-F5CC-4C55-AFCD-907B2EEE382CQ33654631-94722790-5E03-406F-9774-BC9CE3F856C5Q33750892-BB012A9D-7794-4B95-92B5-B101A4C0A9B9Q33839050-35E609E0-9C4A-49BD-901E-90785FA81849Q34098654-B1088ED1-79AF-4079-8EC1-06599B87C97FQ34418375-1E84156F-8586-4DED-8A2F-C25D3DE48BB0Q34540918-656F2305-22DC-40F0-9693-BA834BBA7C0EQ34626423-EFA1E356-5F4B-4173-AFC8-EF0F97C1C811Q35039651-8526D73B-E363-43AE-A2E9-F27DDD65E63DQ35087093-34476B82-1280-4586-AA65-E73267BAAFD9Q35164440-71B6509F-2910-427C-8392-929647DA8397Q35217080-D0A2E0CE-55BF-4A87-937A-304FBAFB881BQ35248556-11BBF983-0386-42C9-9998-2CBCD02AC1C6Q35467022-4343A4A2-AA0B-4550-BEDD-DDF47516769AQ35484057-06C33FB7-71BE-48CD-81BB-65E099BF1E04Q35537460-C5CF9034-D66E-4B01-BFAE-6F896AD5E11FQ35574631-97F9488A-7BC4-4F14-A804-9DDBF90CF1C0Q35593805-0FD3D910-948F-470D-9E17-7902138A5805Q35609321-4474ECBB-6D8D-4BB3-B279-BAAC852AF941Q35819324-464DCCB5-D266-472F-973D-8EE759312EB3Q35864966-8224573E-0433-4A87-945D-67C40BC1B4BAQ35910659-ADFF6385-1C1C-47D4-A4D1-932FE94D0853Q36142629-4787510F-73A8-4EAA-AF92-8C0406D182DA
P2860
description
1997 nî lūn-bûn
@nan
1997 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Epidemiology of peripheral neuropathy
@ast
Epidemiology of peripheral neuropathy
@en
type
label
Epidemiology of peripheral neuropathy
@ast
Epidemiology of peripheral neuropathy
@en
prefLabel
Epidemiology of peripheral neuropathy
@ast
Epidemiology of peripheral neuropathy
@en
P2860
P356
P1476
Epidemiology of peripheral neuropathy
@en
P2093
P2860
P304
P356
10.1136/JNNP.62.4.310
P407
P577
1997-04-01T00:00:00Z